- Home
- Health Topics
- Articles
- Video


Aptivus is a medicine that is often prescribed with ritonavir for the treatment of HIV and AIDS. This eMedTV resource describes how Aptivus works, explains what you should know before taking the drug, and lists possible side effects that may occur.
Fever, nausea, and diarrhea appear to be the most common side effects of Aptivus. This segment from the eMedTV library lists other common Aptivus side effects, as well as less common but potentially serious problems that require medical attention.
Aptivus uses are primarily concerned with treating HIV infection and AIDS in adults. This article from the eMedTV Web site explains how the medication works, describes its effects, and discusses possible off-label Aptivus uses and uses in children.
The recommended Aptivus dosage is 500 mg twice a day, combined with 200 mg of ritonavir. This eMedTV segment offers more detailed Aptivus dosing guidelines and includes a list of tips and precautions for those taking the HIV medication.
Medications that can cause negative interactions with Aptivus include statins, abacavir, and pimozide. This eMedTV Web page includes a more complete list of medicines that can cause Aptivus drug interactions and describes the possible effects.
There have been reports of bleeding in the brain in people taking Aptivus. This eMedTV segment offers other important Aptivus warnings and precautions, and also includes information on who should not take the HIV medication.
An Aptivus overdose will most likely cause the regular side effects, but perhaps more severely. This eMedTV article further discusses the possible effects of an Aptivus overdose and explains the treatment options that are available.
According to certain animal studies, Aptivus may not be safe for use during pregnancy. This eMedTV article contains more information on Aptivus and pregnancy, and describes the problems that occurred when the drug was given to pregnant rabbits.
Women with HIV or AIDS (including those taking Aptivus) are typically advised to avoid breastfeeding. This eMedTV page offers more information about Aptivus and breastfeeding, and explains why it may be dangerous for women with HIV.
Aptivus is not available in generic form at this time. As this eMedTV resource explains, while the drug is currently under the protection of a patent, companies can begin making generic Aptivus products as soon as this patent expires in May 2014.
| Referring Pages | Articles |